Atacand 32 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FJLFD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,375
Award facts
- Contract value 100% obligated
- $14,374.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $14,374.90 by the Defense Logistics Agency (DLA) for the supply of Atacand 32 mg tablets (90-count). The contract, which does not utilize a set-aside designation, was awarded on September 15, 2025, with an ultimate completion date of September 16, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $499,999,999 master contract valid through November 2026 that authorizes the issuance of firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities.
Atacand (candesartan), an antihypertensive medication, will be delivered to the place of performance in Park Ridge, Illinois. This award reflects DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete in federal procurement while maintaining a substantial portfolio of pharmaceutical product deliveries to Department of Defense healthcare sites. The company's consistent award history with DLA demonstrates its capability to reliably supply both branded and generic prescription medications, over-the-counter products, and specialty pharmaceuticals to support military medical operations.
Quick answers
Who was awarded contract SPE2DB25FJLFD?
SPE2DB25FJLFD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FJLFD worth?
The government has obligated $14,375 on SPE2DB25FJLFD.
Is contract SPE2DB25FJLFD an order under another contract?
Yes. SPE2DB25FJLFD is a delivery order under SPE2DB24D9802, an indefinite delivery contract.
Was contract SPE2DB25FJLFD competed?
The extent of competition for SPE2DB25FJLFD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award